Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000082

CEO bought 12,000 shares at an average $0.11 ($1,360)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-07-13 Purchase : show line 1 in the form +5,000 $0.13 $650 7,024,314 D
2016-07-13 Purchase : show line 2 in the form +5,000 $0.10 $500 7,029,314 D
2016-07-13 Purchase : show line 3 in the form +2,000 $0.11 $210 7,031,314 D
Open-market purchases · 12,000 sh · avg $0.11 · $1,360
Loading xslF345X03/primary_doc.xml…